Search

Home > JACC's Audio Podcasts > JACC - Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy
Podcast: JACC's Audio Podcasts
Episode:

JACC - Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy
Category: Science & Medicine
Duration: 00:14:01
Publish Date: 2024-11-20 14:25:36
Description:

JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy of the SUMMIT trial published in JACC and presented at AHA, demonstrating that tirzepatide therapy in obesity-related HFpEF led to reduced LV mass and paracardiac adipose tissue as compared to placebo and the change in LV mass paralleled weight loss. These physiologic changes may contribute to the reduction in heart failure events seen in the main SUMMIT trial.
Total Play: 0

Users also like

100+ Episodes
Podcasts de .. 50+     7
400+ Episodes
CHEST Journa .. 10+     2
1 Episodes
JAMA Cardiol .. 10+     5

Some more Podcasts by American College of Cardiology

500+ Episodes
JACC: Clinic .. 10+     1
1K+ Episodes
JACC Podcast